Skip to main content
. 2019 Mar 9;8(2):155–170. doi: 10.1007/s40121-019-0239-0

Fig. 1.

Fig. 1

Structure of plazomicin and modification sites. The hydroxyamino butyric acid (HABA) substituent (green dotted line) at position 1 and the hydroxyethyl compound addition at the 6′-N position, enhancing plazomicin’s activity against various aminoglycoside-modifying enzymes. The 2′-N position remains unblocked to AACs